3 pharmaceutical giants lose ruling on pricing
300628
US District Judge Patti B. Saris ruled against pharmaceutical companies AstraZeneca PLC , Schering-Plough Corp. , and Bristol-Myers Squibb Co. in Boston yesterday, finding them guilty of engaging in unfair and deceptive trade practices for their medication prices, according to the law firm of Hagens Berman Sobol Shapiro LLP.
174211
A drug manufacturer has been found to infringe patents licensed by the maker of a rival drug.
77441
AstraZeneca, Bristol-Myers Squibb and Schering-Plough must pay damages for overcharging on certain drugs.
205489
NEW YORK - Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets because of severe side effects left the pharmaceutical sector mixed Thursday.
343005
A regulatory panel&#39;s Thursday decision not to recommend approval of Proctor &amp; Gamble Co.&#39;s sex-drive patch for women slammed shares of BioSante Pharmaceuticals Inc.
507965
A federal appeals court has struck down a bid by the District to control the price of prescription drugs sold in the city, concluding that the effort to protect D.C. residents from excessively high costs violates federal patent law.
292172
Merck &amp; Co., the second-largest US drugmaker, lost its AAA credit rating from Standard &amp; Poor&#39;s because of revenue losses and potential liabilities from the company&#39;s September recall of the Vioxx painkiller.
161543
Shares in pharmaceutical giants AstraZeneca PLC and GlaxoSmithKline PLC tumbled Friday after a US safety official raised concerns over key drugs sold by the companies.
557
TRENTON, N.J. -- A federal court invalidated the patent yesterday for Merck &amp; Co.'s second-largest-selling drug, the blockbuster osteoporosis treatment Fosamax, in a decision that offers millions of patients hope for a cheaper version sooner, but darkens the company's already clouded outlook.
372947
Stocks of branded and generic drug makers closed down a bit Tuesday as clinical study results mixed with merger updates. One of the big winners on the day was Nektar Therapeutics, on news that Exubera, the
335223
OAKLAND, Calif. -- Pfizer Inc. , the world's largest drug maker, and 14 other pharmaceutical companies were accused by a group of California drugstores in a lawsuit of conspiring to keep lower-priced medicines from Canada out of the US market.
105959
Shares of the Medicines Co.  fell 10 percent on Monday after the U.S. Congress failed to enact a bill that would have helped the company's bid to extend a patent on its flagship drug Angiomax, a blood thinner.
619726
AstraZeneca, the Anglo-Swedish pharmaceutical group, suffered another setback when it suspended marketing of Iressa, a lung cancer drug launched this year.
252707
Sanofi-Aventis has withdrawn its  marketing application for its Multaq heart arrhythmia treatment  in the European Union, the world's third-largest drugmaker said  on Thursday.
311418
Investors in pharmaceuticals were dealt  a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and  Eli Lilly and Co all shocked the market with bad news about key  products.
443779
Investors in pharmaceuticals were dealt a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and Eli Lilly and Co all shocked the market with bad news about key products.
680868
Sanofi-Aventis's anti-obesity drug Acomplia is facing three generic competitors in India even before it has won full approval from some markets, Les Echos newspaper reported on Thursday.